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Abstract
Toxoplasma gondiimaintains its intracellular life cycle using an extraordinary arsenal of par-
asite-specific organelles including the inner membrane complex (IMC), rhoptries, micro-
nemes, and dense granules. While these unique compartments play critical roles in
pathogenesis, many of their protein constituents have yet to be identified. We exploited the
Vicia villosa lectin (VVL) to identify new glycosylated proteins that are present in these
organelles. Purification of VVL-binding proteins by lectin affinity chromatography yielded a
number of novel proteins that were subjected to further study, resulting in the identification
of proteins from the dense granules, micronemes, rhoptries and IMC. We then chose to
focus on three proteins identified by this approach, the SAG1 repeat containing protein
SRS44, the rhoptry neck protein RON11 as well as a novel IMC protein we named IMC25.
To assess function, we disrupted their genes by homologous recombination or CRISPR/
Cas9. The knockouts were all successful, demonstrating that these proteins are not essen-
tial for invasion or intracellular survival. We also show that IMC25 undergoes substantial
proteolytic processing that separates the C-terminal domain from the predicted glycosyla-
tion site. Together, we have demonstrated that lectin affinity chromatography is an efficient
method of identifying new glycosylated parasite-specific proteins.
Introduction
Toxoplasma gondii is an obligate intracellular parasite in the phylum Apicomplexa that is capa-
ble of infecting any mammal and causes serious disease in immunocompromised individuals
and congenitally infected neonates [1, 2]. Other apicomplexans of medical importance in
humans include Plasmodium falciparum, the causative agent of malaria and Cryptosporidium
spp, which cause diarrhea in immunocompromised patients [3, 4]. The phylum Apicomplexa
also contains a wide array of animal pathogens such as Neospora caninum (a pathogen of dogs
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and cattle), Eimeria spp (chickens), and Theileria spp. (cattle) that together cause substantial
economic losses worldwide. Genome sequencing of these organisms has revealed that as much
as half of their proteins are unique to these parasites and are not present in their mammalian
hosts, thereby representing a large number of candidates for novel therapeutic interventions
that target parasite-specific proteins and pathways.
The large number of parasite-specific proteins in the Apicomplexa is accompanied by a
series of unique organelles that compartmentalize parasite functions. In particular, the secre-
tory pathway contains specialized organelles named micronemes, rhoptries and dense granules
that play critical roles in invasion, hijacking host functions, and nutrient acquisition. These
organelles secrete their protein constituents at distinct stages during the invasion, resulting in
the release of waves of secretory proteins to actively invade and hijack their mammalian host
cells. Invasion begins when the micronemes secrete adhesins onto the plasma membrane of
Toxoplasma to attach the parasite to the host membrane and activate gliding motility used for
penetration via a parasite-derived actin-myosin motor [5]. After this initial attachment, the
parasite reorients its apical end toward the host cell, followed by the secretion of rhoptry pro-
teins [6]. The rhoptries carry two cargos from two distinct compartments of the organelle, the
rhoptry neck (RONs) and the rhoptry body proteins (ROPs). A subset of the RONs is injected
into the host membrane as complex that facilitates parasite entry. In contrast, the ROPs are
secreted into the host cytosol where they localize to the parasitophorous vacuole (PV), the host
nucleus, or remain in the host cytosol [7]. These ROPs serve as effectors that hijack host cell
machinery to evade innate immunity and ensure the survival of the parasite within the host.
Finally, the parasite secretes dense granule proteins (GRAs) into the PV to remodel the intra-
cellular environment. Recently, a few GRAs have been shown to exit the vacuole into the host
cytosol where they can translocate to the nucleus and modulate host functions [8]. Thus, Toxo-
plasma secretes micronemes, rhoptries, and dense granules in a temporal manner to ensure
successful invasion and survival in the host cell.
Another important parasite-specific organelle is the inner membrane complex (IMC). The
IMC is composed of Golgi-derived membrane stacks supported on a network of intermediate fila-
ments. The membrane stacks are stitched together to span the parasite from the apical cap to the
basal end of the parasite. The IMC plays a key role in host cell invasion by mounting the actin-
myosin motor that functions in motility and host cell penetration, whose components together
are known as the glideosome [9]. In addition, the Toxoplasma IMC plays a key role in endodyo-
geny, the unusual method of cellular division by internal budding in which two daughter parasites
are formed inside of the mother and ultimately consume the mother to release the daughter cells.
Disruptions of certain IMC proteins have resulted in endodyogeny or motility/invasion defects,
highlighting the critical role of this compartment in apicomplexan infections [10].
Previous studies have shown that Toxoplasma has the capacity to post-translationally mod-
ify proteins via both N-linked and O-linked glycosylation [11, 12]. In Toxoplasma, the impor-
tance of N-linked glycosylation was revealed when parasites were treated with tunicamycin,
resulting in replicative parasites within in the host cell, but which then become immotile and
unable to invade new cells [13]. This defect was at least partially explained by the demonstra-
tion that the gliding associated protein GAP50 requires N-glycosylation for proper trafficking
and association with glideosome partners [14]. Less is known regarding the role of O-linked
glycosylation in apicomplexan parasites, which has mostly been studied by lectin staining in
Toxoplasma bradyzoites [15]. Consistent with a primary role in encysted forms of the parasite
disruption of TgNST1, which transports UDP-GalNAc, results in no apparent effects in the
tachzyoite stage, but does affect the formation of bradyzoite tissue cysts in the brain [16]. Thus,
the extent of O-linked glycosylation in tachyzoite and bradyzoite proteins in Toxoplasma and
the functions of these proteins remain largely unknown.
O-Linked Glycosylated Proteins in Toxoplasma
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In this manuscript, we have exploited the O-linked glycosylation system in Toxoplasma to
identify novel proteins and examine their glycosylation and function in tachyzoites. We affinity
purified a subset of these proteins using the Vicia villosa lectin that specifically stains Toxo-
plasma parasites and binds to O-linked N-acetylgalactosamine (GalNAc). Using this approach,
we were able to identify known proteins as well as novel proteins that localize to the micro-
nemes, rhoptries, parasitophorous vacuole and the IMC. We evaluated several of these proteins
and assessed function via gene knockout. Together, this study identifies the major VVL-bind-
ing proteins in Toxoplasma and demonstrates that utilizing lectins to identify novel proteins is
an efficient method to explore and screen for parasite-specific proteins.
Results
Vicia villosa lectin preferentially labels the Toxoplasma secretory
compartments
To identify novel glycosylated proteins in Toxoplasma, we stained intracellular parasites with a
panel of nine fluorescent lectins (Vector Labs, see materials and methods). One of these, Vicia
villosa lectin (VVL), stained brightly in the parasites but not in the host cell. Surprisingly, the
staining pattern with VVL-FITC varied dramatically depending on the fixation conditions.
Using formaldehylde fixation, the lectin stains predominantly in the apical portion of the para-
site with some posterior and vacuolar staining (Fig 1A and 1B). To evaluate what structures
VVL is labeling, we co-stained the parasites with markers for various organelles, including the
inner membrane complex (IMC3), the micronemes (MIC2), the golgi (GRASP55), and the
dense granules/ parasitophorous vacuole (GRA14) (Fig 1C). We observed some co-localization
at the periphery (Fig 1C, arrowhead) and in daughter buds (arrow) with IMC3. Co-localization
was also seen in the apical end of the parasite with MIC2, and in the vacuole with GRA14, but
not in the golgi. In methanol fixation, however, VVL stains exclusively club-shaped organelles
Fig 1. Vicia villosa lectin staining in Toxoplasma. (A-D) VVL-FITC was used to stain and visualize
intracellular parasites using (A-C) formaldehyde fixation, or (D) methanol fixation. (A) Formaldehyde fixation
results in both apical and posterior staining in the parasites, (B) some vacuoles also show staining in the
vacuole (arrow). (C) Co-staining of VVL with IMC3 shows some co-localization at the periphery (arrowheads)
and in daughter buds (arrow). Co-staining was also seen at the apical periphery with micronemes (MIC2,
double arrowheads), and in the vacuole with GRA14 (asterisk), but not in the golgi (GRASP55). (D) Methanol
fixation results in specific staining in the rhoptries as shown by co-localization with ROP7. Scale bar is 20μm.
doi:10.1371/journal.pone.0150561.g001
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in the apical end of the parasites, consistent with the rhoptries (Fig 1D). This was confirmed
via co-localization with the rhoptry body protein ROP7, demonstrating that VVL does indeed
label this compartment under methanol fixation conditions.
Identification of VVL-binding proteins
To identify the VVL-binding proteins in T. gondii, we prepared a large-scale lysate in radioim-
munoprecipitation (RIPA) buffer and subjected it to VVL affinity chromatography. Following
binding to the VVL column and washing, VVL-binding proteins were eluted using the compet-
ing sugar (GalNAc) (Fig 2A). We then ran the elution on a SDS-PAGE gel and detected VVL-
binding proteins byWestern blot and Commassie blue staining (Fig 2B and 2C). To identify spe-
cific proteins in each band, we excised the six most prominent bands, digested them with trypsin,
and subjected them to mass spectrometry. The returned data provided us a list of the most abun-
dant proteins that were eluted from the VVL affinity chromatography (Fig 2D, S1 Fig).
The most abundant protein in the eluted material was present in band 2 at ~125 kDa and
corresponded with gene model TgME49_226830. This protein shares similarity with DnaK
heat shock family proteins. BLAST analysis shows the highest similarity to a protein annotated
as an ER lumen localized HSP70-like protein in Neospora caninum. Consistent with this,
TgME49_226830 and its Neospora orthologue (NcLIV_046170) contain a predicted signal pep-
tide at the N-terminus and the amino acid sequence REEL at the extreme C-terminus, a KDEL-
like ER retention signal that has been documented previously in other ER proteins [17]. The
Fig 2. Identification of VVL-binding proteins. (A) Schematic for identifying VVL-binding proteins. (B, C)
VVLWestern blot (B) and commassie staining (C) of the eluted materials from VVL affinity chromatography.
(D) Proteins identified from the VVL pull down. The bolded proteins are the ones we either discuss or study in
the paper.
doi:10.1371/journal.pone.0150561.g002
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next most abundant bands (bands 3,4,5) all gave top hits to the micronemal subtilisin-like pro-
tease TgSUB1, which has been previously shown to be processed into multiple fragments [18].
SRS44 (CST1) is a vacuolar VVL-binding protein
At the top of the gel of VVL-eluted proteins, a high molecular weight protein was identified
which corresponds to SRS44, also known as CST1. SRS44 has recently been described as an
important component for maintaining integrity of the bradyzoite cyst wall [19]. SRS44 is
unusual in that it contains 13 tandem repeats of the SRS domain followed by a mucin-like
domain and also lacks the predicted GPI anchor seen on most SRS proteins. Mucins are typi-
cally modified by O-linked glycosylation and are also known to bind VVL [20]. This region of
SRS44 contains a stretch of over 100 threonines (interspersed with lysine, arginine and proline)
that are highly predicted to be glycosylated by the NetOGlyc prediction program [21]. As cur-
rent reagents only detect the glycoepitopes of SRS44, we expressed residues 803–1288 as a
6xHis tag fusion protein in E. coli, purified the recombinant protein using Ni-agarose, and
injected the protein into mice for antibody production. Staining of intracellular tachyzoites
demonstrated that SRS44 localizes to the parasitophorous vacuole. Surprisingly, SRS44 was
detected strongly in some vacuoles, but was completely absent in others in standard infections
(Fig 3A and 3B). The variability is seen in infections using both type I (RH) and type II (Pru)
strain parasites and is more obvious in larger vacuoles (28 hrs, 4–16 parasites) than smaller
ones (12 hrs, 2–4 parasites) (data not shown). To verify specificity of our antibody and assess
the function of SRS44 in RH strain parasites, we disrupted its gene, which resulted in a com-
plete loss of staining with the antibody (Fig 3C). As expected from its previous disruption in
the lower virulence Pru strain parasites, we did not detect any gross defect of the knockout in
culture of the parasites in vitro. The knockout parasites additionally retained their high viru-
lence in mice, consistent with its role in the bradyzoite stage of the parasite (data not shown).
Also consistent with its role in cyst integrity, SRS44 staining of bradyzoites from brain homoge-
nates from mice infected with Pru strain parasites that specifically express GFP in the brady-
zoite stage showed labeling within the cyst and bright staining of the cyst wall (Fig 3D).
TgME49_283540 is a novel microneme protein
The most abundant protein in band 6 corresponded to TgME49_283540, an uncharacterized
protein that contains a predicted signal peptide suggesting localization to one of the parasites
Fig 3. SRS44 is a vacuolar protein with 13 SAG repeats and a C-terminal mucin-like domain. (A-C) IFA labeling with SRS44 polyclonal antibody in
either WT tachyzoites (A,B) or Δsrs44 parasites (C). (A) Staining shows different levels of SRS44 expression between two different vacuoles (B) Staining
shows SRS44 detection in some vacuoles but not all (arrow). (C) Disruption of SRS44was verified by IFA. (D) Mouse brain cysts of the pruΔku80 strain have
a GFP under a bradyzoites (cysts) promoter and show staining of SRS44 on the cyst wall. Scale bar is 20μm.
doi:10.1371/journal.pone.0150561.g003
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secretory organelles, but no identifiable homology to known proteins or domains that might
allude to its function. To localize TgME49_283540, we amplified the entire coding region with
the promoter and cloned this product into a vector that contains a downstream C-terminal HA
tag and the GRA2 3’UTR. Expression of this construct in Toxoplasma revealed apical staining
consistent with the micronemes. Co-staining of parasites expressing TgME49_283540-HA
with MIC2 confirmed micronemal localization and thus we named this novel microneme pro-
tein MIC20 (Fig 4A). To evaluate whether or not MIC20 is likely to be glycosylated, we immu-
noprecipitated the protein with HA from Toxoplasma lysates expressing MIC20-HA. We
obtained a strong enrichment of the target protein and stained Western blots of the eluted
material with biotinylated VVL (Fig 4B). The VVLWestern also showed strongly enriched
staining of the eluted material, indicating that MIC20 is indeed O-glycosylated.
RON11 is present in VVL elutions, and is not essential for growth in vitro
Bands 1 and 2 also contained a rhoptry neck protein that we have recently identified and
named RON11 (Fig 5A) [22]. RON11 was particularly interesting as it is conserved in apicom-
plexan parasites and also contains a calcium-binding domain in the C-terminal region of the
protein. To assess function of this identified protein, we used a single crossover homologous
recombination strategy to eliminate the calcium-binding domain. Integration just upstream of
this domain eliminated staining with our antibody directed against the C-terminal calcium-
binding domain. This integration event was intended to replace the C-terminal region with an
Fig 4. TgME49_283540 is a novel VVL-binding micronemal protein. (A) Heterologous expression of
TgME49_283540-HA is detected in the micronemes, as shown by co-localization with MIC2. (B) VVL
Western blotting of eluted materials fromMIC20-HA pull down confirms that MIC20 is a VVL-binding protein.
doi:10.1371/journal.pone.0150561.g004
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HA tag but the tag could not be detected, suggesting that integration resulted in loss of the pro-
tein altogether, effectively generating a RON11 knockout (data not shown). A similar approach
resulting in complete gene disruption was recently conducted with the micronemal protein
AMA1 [23]. To confirm that RON11 is not essential, we disrupted its gene by CRISPR/Cas9
and confirmed the knockout by loss of staining with our antibody andWestern blot analysis
(Fig 5B and 5C). We first examined the Δron11 parasites for defects in invasion using 1 hour
pulse invasion assays, but did not observe a significant difference in penetration efficiencies
between wild-type and Δron11 parasites. We also examined parasites over a longer time frame
by plaque assays to detect more subtle differences in the lytic cycle (invasion, replication,
egress) and did see a small difference in plaque sizes (Fig 5D). Our attempts to determine if
RON11 is glycosylated using immunoprecipitations similar to that done for MIC20 failed to be
conclusive (not shown).
TgME_218240 is an IMC Protein that is Proteolytically Processed
TgME49_218240 also originated from Band 6 but was detected as a lower abundance hit by
mass spectrometry (Fig 2). We suspected that TgME49_218240 could be a novel IMC or rhop-
try protein because its cell cycle expression profile is similar to known IMC or rhoptry proteins,
it contains a predicted N-terminal signal peptide for entrance into the secretory pathway, and
it also has a predicted transmembrane domain in the C-terminal portion of the protein which
Fig 5. Δron11 parasites show aminor fitness defect compared to theWT. (A) IFA demonstrating RON11
localization to the rhoptry necks in WT parasites, using previously described rat anti-serum raised against
RON11[24]. (B, C) Δron11 parasites were generated via CRISPR/Cas9-mediated disruption of RON11 as
shown by IFA (B) andWestern blot (C). (D) Confluent HFF monolayers were infected with equal numbers of
WT and Δron11 tachyzoites. After seven days of incubation, parasites were fixed and stained with crystal
violet as previously described [24]. For each experiment, 30 plaques were counted and measured from both
theWT and Δron11. The bar graph represents the average mean for three experimental replicates. The error
bars represent ±SD, and a paired two-tails t-test was performed comparing the mean plaque area of each
Δron11 experimental replicates to theWT to assess statistical significance (p = 0.033; *p<0.05).
doi:10.1371/journal.pone.0150561.g005
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could anchor it to the IMC or rhoptry membranes. BLAST analysis reveals that
TgME49_218240 has orthologs in Neospora and Eimeria but lacks any identifiable domains
and homology to any known proteins, suggesting that it plays a unique role in T. gondii and
related parasites.
We then localized TgME49_218240 by endogenous gene tagging with a C-terminal hemag-
glutinin tag. Staining with anti-HA antibodies showed localization at the periphery except for a
small gap at the extreme apical and basal ends of the parasite, characteristic of the IMC [25].
Staining of parasites that were undergoing endodyogeny showed that the daughter buds were
also detected, demonstrating that TgME_218240 is indeed an IMC protein, which we thus
named IMC25 (Fig 6A). To access the function of IMC25, we disrupted its gene using CRISPR/
Cas9. A clone of Δimc25 parasites was obtained by limiting dilution, confirming that IMC25 is
not essential. The knockout was confirmed by IFA and Western blot (Fig 6B and 6C). We
examined growth by plaque assay and saw no gross defect in growth (data not shown). In addi-
tion, we did not see any defects in parasite endodyogeny by labeling daughter buds with ISP1
and IMC1 antibodies (data not shown)
Surprisingly, Western blot analysis of IMC25 on the epitope tagged strain revealed a pre-
dominant band at 25kDa and a less prominent 20kDa band whereas the predicted protein size
is predicted to be ~132kD. This suggests that IMC25 is proteolytically processed, yielding 25
and 20kd C-terminal fragments. To determine if the C-terminal region of IMC25 is linked to
the region of the protein that contains the sites predicted for O-linked glycosylation, we pulled
down the glycosylated proteins with VVL (predicted to bind O-GalNAc sites on IMC25
upstream of the predicted cleavage event) and probed a Western blot of the lectin-pull down
with anti-HA antibodies. Only the unprocessed (132kD) and partially processed (75kD) forms
of IMC25 were present in the elution, indicating that the O-linked sites are upstream of the
cleavage site. This agrees with O-linked glycosylation prediction programs that strongly predict
Fig 6. TgME49_218240 is an IMCmembrane protein that is proteolytically processed. (A) TgME49_218240-HA shows IMC staining in both the
maternal IMC and in daughter buds in parasites undergoing endodyogeny. (B, C) The IMC25 gene was disrupted via CRISPR/Cas9 and Δimc25 parasites
were confirmed by IFA (B) andWestern blot (C). (D) VVL pull downWestern blot probed with anti-HA antibody showing total (T), precolumn (S), flow through
(FT) and elution (E). The eluted material detects the less abundant IMC25 precursors, indicating that the glycosylation is upstream of the IMC25 cleavage
site (~20–25 kDa). This also suggests that the C-terminal fragments of IMC25 are not linked to the larger upstream glycosylated portion of IMC25. (E)
Detergent extraction demonstrates that IMC25-HA is detergent-labile (T = total, S = detergent soluble, P = detergent insoluble IMC cytoskeleton),
demonstrating that this portion of IMC25 is part of the membrane portion of the IMC. ISP3 and IMC1 are used as controls for the membrane and cytoskeletal
portions of the IMC, respectively.
doi:10.1371/journal.pone.0150561.g006
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O-glycosylation of a series of threonine residues that are upstream of the C-terminal region
[21]. The result also indicates that the 25 and 20 kD fragments do not co-precipitate with the
lectin-bound portion and thus these regions of the processed protein do not bind to each other
tightly (Fig 6D). In addition, detergent extraction suggests that IMC25 is part of the membrane
portion of the IMC as it is detected only in the supernatant with ISP3, a known membrane
IMC protein (Fig 6E) [10].
Discussion
In this study, we evaluated a panel of lectins for ones that stain T. gondiimore strongly com-
pared to host cells to provide an initial localization of glycosylated proteins as well as providing
a straightforward method for isolating new proteins that might be involved in parasite patho-
genesis. The most robust staining was obtained via VVL, which suggested targets in the vacu-
ole, apical regions and rhoptries. The reason for enhanced staining of parasites is unknown,
however, this lectin has a preference for single N-acetylgalactosamine residues and may require
specific amino acid sequences at the site of glycosylation that could contribute to the staining
observed [26].
VVL provides a useful tool for the identification of unique parasite proteins within the para-
site whose glycosylation either plays a minor role in their function or can be compensated by
other factors upon loss of function. The mass spectrometry from the VVL pull down resulted
in the identification of six proteins from various subcellular compartments in Toxoplasma. The
first of these hits, TgME49_226830, is predicted to be an ER localized heat shock protein that
we decided to not pursue further. The second most abundant protein isolated protein is the
micronemal processing protease TgSUB1, which processes adhesive complexes that are neces-
sary for proper gliding motility, attachment, and virulence [18]. TgSUB1 has been previously
shown to be processed into multiple forms, in agreement with the multiple bands isolated in
our pulldown. Interestingly, previous work on SUB1 noted aberrant migration of the processed
protein fragments, which is likely to be explained by glycosylation as suggested by its binding
to VVL.
The next protein from the VVL pull down was the previously described bradyzoite cyst wall
component SRS44 (or CST1), which was originally identified by dolichos biflorus agglutinin
(DBA) lectin that also recognizes O-linked GalNAc [19]. SRS44 is an unusual protein with 13
repeats of SAG1-like sequences, no GPI anchor, and a C-terminal mucin-like domain that is
strongly predicted to be O-glycosylated (similar to other mucin domains). While SRS44 is
important for integrity of cysts in vivo, we see that it is also substantially expressed in tachy-
zoites. This is consistent with mass spectrometry and expression evidence from the Toxo-
plasma genome (www.Toxodb.org). The variability of SRS44 staining of individual vacuoles is
surprising, and far more dramatic than any variability we have seen with other vacuolar GRA
proteins. It is formally possible that these vacuoles are undergoing some stress and that staining
represents an early transition to bradyzoites, but this seems unlikely as staining is present in
the majority of vacuoles and we don't observe staining of bradyzoite markers (e.g. SRS9) in
these samples (not shown). Alternatively, it is possible that SRS44 could be degraded in the
environment of some vacuoles or that parasites within some vacuoles may cease to secrete the
factor.
We also identified a new microneme protein that we named MIC20 via VVL affinity chro-
matography. MIC20 lacks apparent adhesive or transmembrane domains commonly seen in
other microneme proteins. MIC20 could be a member of a multiprotein adhesive complex,
similar to MIC2/MIC2AP, MIC1/4/6, or MIC3/8 [27, 28]. We did not address the function of
MIC20 as BLAST analysis revealed that there is a paralogue for this protein (TgME49_239430)
O-Linked Glycosylated Proteins in Toxoplasma
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that also contains a predicted signal peptide in the Toxoplasma genome. Determining the local-
ization of this protein will help to assess if it is a related microneme protein that may have a
redundant or similar function to MIC20.
The fourth protein, TgME49_230350, has been previously identified by our lab as a rhoptry
neck protein (RON11) that contains a calcium-binding domain [22]. Elevated cytosolic cal-
cium released from intracellular stores has been shown to regulate the secretion of the micro-
nemes, resulting in driving motility and invasion [29]. In addition, the subsequent drop in
calcium is correlated with rhoptry discharge [30]. RON11 is highly conserved in apicomplex-
ans, suggesting an important role in rhoptry-mediated functions. Surprisingly, we were able to
disrupt RON11 without any gross effects on invasion or intracellular survival. It is possible that
some other protein is compensating upon the loss of RON11, as compensation has been
increasingly detected in knockouts in T. gondii [23, 24, 31]. BLAST analysis reveals one protein
with low similarity to RON11 (TgME49_239430), but this gene is likely to be very lowly
expressed. We attempted to endogenously epitope tag this gene in both wild-type and knock-
out parasites and could not detect any expression. It is also possible that RON11’s function is
restricted to a particular host cell or host, which would be better evaluated by lower virulence
strain parasites. Many RON proteins exist in protein complexes, thus identifying partners by
pull-down experiments may help to reveal the function of RON11. To identify possible interac-
tors, we attempted to use the in vivo biotinylation (BioID) approach that we recently adapted
to T. gondii, but the fusion protein mistargeted and was inactive (not shown).
The last protein that was identified from the pull down is a novel uncharacterized protein,
TgME49_218240 that localizes to the inner membrane complex of Toxoplasma, named
IMC25. Western blot analysis suggests IMC25 is processed from 132kD to 25 kD or 20kD frag-
ments. This is interesting because little is known about IMC protein processing events and this
protein could provide information on the types of cleavage events that are present in the organ-
elle. We presume that IMC25 is anchored in the membrane portion of the IMC via its trans-
membrane domain and is not tightly anchored to the cytoskeleton, as it readily released in TX-
100 extractions of the parasite (Fig 5C).
Together, the VVL affinity approach provides an effective method for identifying novel par-
asite factors that are modified by O-linked glycosylation. While we have identified a number of
the most prominent VVL-binding proteins, there are likely to be substantially more proteins
that are lower in abundance and/or have few GalNAcs. The bulk of these would best be identi-
fied by deeper mass spectrometric analyses using MudPIT of the entire eluted fraction. In addi-
tion, this technique could be extended to determine specific sites of glycosylation by more in
depth mass spectrometry of identified hits. While transport of GalNAcs via TgNST1 is not
essential in tachyzoites, it is likely that these modifications affect the stability or activity pro-
teins that are glycosylated. The development of methods for rapid endogenous tagging of genes
in Toxoplasma combined with CRISPR/Cas9 based knockout systems make analyses of large
numbers of these proteins even more feasible in the future.
Materials and Methods
Ethics statement
All animal studies were approved by the animal research committee at UCLA (ARC #2004–
016, 2012–038, and 2012–077). The UCLA animal facility is accredited by the AALAC. All pro-
cedures including housing and welfare were carried out in accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. Specific details of our protocol were approved by the UCLA Chancellor’s Animal
Research Committee (ARC#2004–055).
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Toxoplasma and host cell culture
T. gondii RHΔhxgprt (parental) strain and modified strains were maintained in confluent
monolayers of human foreskin fibroblast (HFF) host cells as previously described [32].
Antibodies
The following primary antibodies were used in IFA or Western blot: anti-MIC2 [28], anti-
GRA14 [33], anti-ROP7 (Monoclonal antibody [MAb] 1B10) [33], anti-SRS44, anti-IMC3
[34], mouse anti-ISP3 [10], anti-IMC1 mAb 45.15 [35], rat anti-RON11 [24], VVL-FITC (Vec-
tor laboratories), and biotinylated-VVL (Vector laboratories). Hemagglutinin (HA) epitope
was detected with mAb HA.11 (Covance) and rabbit polyclonal anti-HA (Invitrogen). For
localization of GRASP55, a fluorescent fusion was used as previously described [36].
IFA andWestern blotting
For IFA, HFFs were grown to confluence on coverslips and infected with T. gondii parasites.
After 18 to 36 h, the coverslips were fixed and processed for indirect immunofluorescence as
previously described [37]. Primary antibodies were detected by species-specific secondary anti-
bodies conjugated to Alexa 594 or 488. For the lectin staining, samples were incubated with a
panel fluorescein labeled lectins diluted 1:300 (Vector Laboratories: Vicia villosa agglutinin,
Solanum tuberosum lectin, Lycopersicon esculentum lectin, Erythrina cristagalli lectin, Datura
stramonium lectin, Griffonia simplicifolia lectin II, Jacalin, Ricinus communis agglutinin I,
Wheat Germ agglutinin). The coverslips were mounted in Vectashield (Vector Labs) and
viewed with an Axio Imager.Z1 fluorescence microscope (Zeiss) as previously described [10].
For Western blotting, parasites were lysed in Laemmli sample buffer (50 mM Tris-HCl [pH
6.8], 10% glycerol, 2% SDS, 1% 2-mercaptoethanol, 0.1% bromophenol blue), and lysates were
resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Blots were probed
with the indicated primary antibodies followed by secondary antibodies conjugated to horse-
radish peroxidase (HRP) or VVL conjugated to biotin followed by streptavidin-HRP. An ECL
detection kit was used for the detection of HRP activity (Thermo Scientific) and target proteins
were visualized by chemiluminescence.
Affinity Purification of VVL-binding proteins
For purification of VVL-binding proteins, parasite lysates were made in 0.5% NP-40 buffer
(50mM Tris ph 7.5, 150mMNaCl, and 0.5% NP-40) with Complete Protease Inhibitor Cocktail
(Roche). Extracellular parasites (2 x 109) were centrifuged at 3000g for 20 min. The parasites
were washed once in 1X PBS and then lysed on ice for 20 min prior to removing insoluble
material by centrifugation at 10,000g for 15 min. The vvl-conjugated beads were incubated
with the lysate at 25°C for 2 hours before five washes with the lysis buffer. The bound proteins
were eluted using lysis buffer supplemented with 100mMN-acetylgalactosamine. Five fractions
were collected and analyzed by Western blot using biotinylated VVL (1:300).
Generation of Polyclonal Anti-sera against SRS44
Sequences encoding amino acids 803–1288 of SRS44 were PCR amplified from a template of T.
gondii strain RH genomic DNA with primers P1 and P2 (See Table 1) and then subcloned into
the pET151GW-D-TOPO vector which encodes a C-terminal 6xHis tag for purification. The
plasmid was transformed into E. coli BL21 (DE3) cells and grown to an A600 of 0.6 before the
bacteria were induced using isopropyl-1-thio-d-galactopyranoside for 5 hours. Recombinant
SRS44803-1288 protein with the 6xHis tag was purified using Ni-nitrilotriacetic acid-agarose
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chromatography under denaturing conditions and eluted using a low pH according to the
manufacturer's guidelines (Qiagen). The purified protein was dialyzed against phosphate-buff-
ered saline (PBS) and ~100 μg of protein was injected per immunization into BALB/c mice
(Charles River) on a 21-day immunization schedule. The resulting mouse polyclonal antiserum
was collected and tested by Western blot analysis and IFA.
To examine staining of SRS44 in bradyzoites, C57Bl/6 mice were infected with 500 Pru
strain parasites that also contain GFP driven from the bradyzoites specific BSR4 promoter. At
31 days post infection, the mice were sacrificed, brains homogenized, fixed, and stained with
anti-SRS44 antibodies and viewed for the presence of the protein and GFP by fluorescence
microscopy.
Disruption of SRS44 via double homologous recombination
Deletion of the SRS44 gene was accomplished by homologous recombination using a construct
derived from the pMini-GFP.ht knockout vector which contains the selectable marker hypo-
xanthine-xanthine-guanine phosphoribosyltransferase (HPT) and also contains the green fluo-
rescent protein (GFP) as a downstream marker to distinguish homologous and heterologous
recombinants [38]. The 50 flank (1,320 bp) and 30 flank (1,256 bp) of SRS44 were amplified
using primer pairs P3/P4 and P5/P6, respectively. These genomic flanks were then cloned into
pMini-GFP.ht upstream and downstream of HPT, resulting in the vector pSRS44-KO-HPT.
30 μg of pSRS44-KO-HPT was transfected into RHΔhpt parasites and selection for HPT was
applied 12 hours post-transfection using 50 μg/ml mycophenolic acid and 50 μg/ml xanthine.
Surviving parasites were cloned by limiting dilution eight days post-transfection and screened
for GFP by fluorescence microscopy. GFP-negative clones were assessed for absence of SRS44
staining by IFA.
Virulence studies with Δsrs44 parasites
To evaluate the virulence of Δsrs44 parasites, 100 knock out parasites were injected into female
6-week old C57Bl/6 mice. All mice became moribund with the same kinetics as infections with
wild-type parasites, demonstrating no change in virulence in vivo. All procedures were in
accordance with the UCLA ARC (protocol #55–044).
Table 1. Oligonucleotide primers used in this study.
Name Description Sequence
P1 SRS44803-1288 for antibody production Sense CACCAACTCTATGACGAGGCTGTCC
P2 SRS44803-1288 for antibody production Antisense CCACATGAACAAGCAGGGACA
P3 SRS44 disruption 5’ Sense w/ NotI GCGGCCGCGCTACTGTCGGTTGTTCCGGTTT
P4 SRS44 disruption 5’ Antisense w/ SpeI ACTAGTGCCTCAGATCTCGGGGTTCTT
P5 SRS44 disruption 3’ Sense w/ XhoI CTCGAGCCGCCGCTACAGTTTGTGG
P6 SRS44 disruption 3’ Antisense w/ KpnI GGTACCGCCAACTGTTCACCCTCTCAAGA
P7 MIC20-HA Sense w/KpnI CAGCGGTACCCCTTTTGTTCA
P8 MIC20-HA Antisense w/NotI GCGGCCGCTATATTGTCATCTTGCTCGCCAGGACC
P9 RON11 gRNA Sense w/ BsaI AAGTTGCGCTTCACGAACAGGGGAGG
P10 RON11 gRNA Antisense w/ BsaI AAAACCTCCCCTGTTCGTGAAGCGCA
P11 IMC25 gRNA Sense BsaI TACTTCCAATCCAATTTAGCCACGACCACGAAGACTCCCGCG
P12 IMC25 gRNA Antisense w/ BsaI TCCTCCACTTCCAATTTTAGCGGCTGACTGTTCGATCAGTGGTCG
P13 IMC25 pHA-LIC Sense TACTTCCAATCCAATTTAGCCACGACCACGAAGACTCCCGCG
P14 IMC25 pHA-LIC Antisense TCCTCCACTTCCAATTTTAGCGGCTGACTGTTCGATCAGTGGTCG
doi:10.1371/journal.pone.0150561.t001
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Second copy-expression of TgME49_283540, MIC20-HA
To epitope tag TgME49_283540, the entire coding region and additional 2 kb sequence
upstream of the gene was amplified using primers P7/P8 (See Table 1), respectively, and cloned
into the pNOT-HA_HPT vector, which encodes a C-terminal HA-tag [33]. The constructs
were linearized and transfected by electroporation into T. gondii strain RHΔhpt. The trans-
fected parasites were grown in medium containing 50 μg/ml mycophenolic acid (MPA) and
50 μg/ml xanthine, and selected parasites were cloned. To assess targeting, parasites were ana-
lyzed by immunofluorescence with rabbit polyclonal HA antibody. Immunoprecipitations of
MIC20 using the HA tag were carried out as described [22].
Gene disruption via the CRISPR/CAS9 system
The knockout of RON11 was accomplished using the CRISPR/CAS9-based system in Toxo-
plasma as previously described [39]. The 20bp protospacer used by the CAS9 system was
designed to make a double stranded break in the Toxoplasma genome in the first exon of
RON11. The protospacer was made by annealing primers P9/P10 (See Table 1) and cloned into
pU6-universal vector via BsaI sites. The final vector was co-transfected into WT parasites with
anHPT cassette at a 5:1 ratio respectively. Parasites were selected with 50 μg/ml mycophenolic
acid and 50 μg/ml xanthine. Eight days post-transfection, surviving parasites were cloned by
limiting dilution and screened by IFA for RON11 negative parasites using the RON11 antibody.
Disruption of IMC25 was similarly conducted with primers P11/P12 (See Table 1).
Plaque assays
Parasites were grown 48 hrs, syringe lysed and infected into 6-well dishes containing fresh,
confluent HFF monolayers. Cultures were allowed to grow seven days for RON11 and nine
days for IMC25 before fixation with methanol followed by staining with crystal violet as previ-
ously described [24].
Epitope tagging of IMC25
For endogenous tagging of IMC25, we used the plasmid p3XHA-LIC-DHFR [22]. The 3’ por-
tion of the IMC25 was PCR amplified with P13/P14 (See Table 1) and inserted into the plasmid
using a ligation-independent cloning approach (LIC) to generate a 3XHA epitope tag fusion
prior to the stop codon of IMC25. The constructs were linearized within the amplified region
and 50 μg of DNA were transfected into RHΔku80Δhpt and cloned by limiting dilution after
selection in drug medium containing 1 μM pyrimethamine. Clones that had undergone the
intended recombination event were screened by IFA andWestern blotting against the 3XHA
tag with mouse monoclonal HA antibody used at 1:1000.
Detergent extractions
Extracellular IMC25-HA parasites were washed in PBS, pelleted, and lysed in 1 ml of 1% Triton
X-100 lysis buffer (50mM Tris-HCl [pH 7.4], 150 mM NacCl) supplemented with Complete
protease inhibitor cocktail (Roche) for 30 min on ice. Lysates were centrifuged for 15 min at
14,000 X g. Equivalent amounts of total, supernatant, and pellet fractions were separated by
SDS-PAGE and analyzed by Western blotting using ISP3 and IMC1 for controls as described
[25].
Accession numbers
Genbank accession numbers: KU550704 for IMC25 and KU550705 for MIC20
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Supporting Information
S1 Fig. Peptides identified in VVL-binding proteins via mass spectrometry. The peptides
that were identified from mass spectrometry in each VVL-binding proteins are highlighted in
red. Some of the identified peptides were derived from multiple bands.
(PDF)
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